Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C
- PMID: 30997352
- PMCID: PMC6463826
- DOI: 10.2478/jtim-2019-0004
Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C
Abstract
Background and objective: Hepcidin is the key regulator of iron metabolism and is a significant biomarker for systemic inflammatory states. Vitamin D is a powerful immunomodulator and plays a significant role in the inflammatory responses and fibrosis occurring due to hepatitis C virus (HCV) infection. This study assessed the level of vitamin D and serum hepcidin and its expression in peripheral blood of children with chronic hepatitis C (CHC) and correlated them with other serum markers to reflect iron metabolism and liver disease severity.
Methods: A total of 100 children were included in this study: 50 with HCV infection and 50 healthy controls. Biochemical parameters together with vitamin D, hepcidin, and its expression were all measured.
Results: The level of hepcidin and its expression together with vitamin D and hepcidin-to-ferritin (H/F) ratios were significantly reduced in patients, but the iron and ferritin levels were higher (P<0.001). Serum hepcidin level showed significant positive correlation with hepcidin expression, HCV titer, iron, ferritin, and H/F ratio (r = 0.43, 0.31, 0.34, 0.28, and 0.91, respectively) but significant negative correlation with vitamin D (r = -0.37). Both hepcidin and ferritin were higher in patients with Child Pugh scores B and C than those with score A (P<0.001).
Conclusion: Measuring serum hepcidin and its expression together with vitamin D levels in patients may have a prognostic value and is promising in the follow-up of the severity of liver disease.
Keywords: hepatitis C; hepcidin; hepcidin-to-ferritin ratio; vitamin D.
Conflict of interest statement
Conflict of Interest The authors report no conflict of interests
Figures

References
-
- Anderson G, Frazer D. Hepatic iron metabolism. Semin Liver Dis. 2005;25:420–32. - PubMed
-
- Nemeth E. Hepcidin biology and therapeutic applications. Expert Rev Hematol. 2010;3:153–5. - PubMed
-
- Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–3. - PubMed
-
- Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie. 2009;91:1223–8. - PubMed
-
- Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology. 2008;48:1420–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous